Emedgene, a startup that employs artificial intelligence to interpret genetic data, has closed a $6 million round led by OliveTree Ventures.
What they do
Trained using data from patient cases, publications and genomics databases, Emedgene’s decision support engine can identify and highlight clinically relevant genetic variants for the provider. The platform is supported by a digital workbench...
A group of consumer genetic and personal genomic testing companies have released a set of best practices for handling consumers’ personal genetic data.
Designed to ensure privacy and promote transparency, the guidelines include a requirement for separate express consent before a company can transfer genetic data to a third party, such as an insurer or employer.
“Supporting strong and transparent...
23andMe on Wednesday announced that GlaxoSmithKline has invested $300 million to gain exclusive access to the genetic testing startup’s DNA database.
The deal comes as GlaxoSmithKline amid reports that GSK is weighing the possibility of a company breakup and investors contending that synergies between consumer markets and big pharma are inherently limited and that GSK’s pharmaceuticals business...
The FTC’s PrivacyCon, an all day event that included presentations and discussions from a number of privacy researchers, one presentation focused on the data privacy risks associated with direct to consumer genomic data services. Many of these risks apply to any consumer health data service.
Researchers Jan Charbonneau and Andelka Phillips, of the University of Tasmania and the University of...
Health data platform company BaseHealth raised $3.6 million, according to an SEC filing. BaseHealth has raised at least $9.1 million to date.
The company has developed a health assessment service, called Genophen, that payors and providers can offer to members and patients. The service can be added as a feature to a customer's existing health and wellness program.
BaseHealth's service collects...
